The Foursquare Framework for investing in HealthTech based on Medicine Needs and Social Needs
Lloyd Price
JULY 30, 2018
In January, a single therapy to treat a rare form of blindness received a price tag of $850,000. In his view, venture capital often lean towards the therapeutics companies that fit into the low social complexity/high medical complexity quadrant, such as costly novel drugs for cancer or diabetes. Who's left out?
84 
Let's personalize your content